Patent · US Active

Methods of inducing melanogenesis in a subject

US10857208B2 · kind B2 · utility

0Cited by
6References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 27, 2018
Grant dateDec 8, 2020
Priority date
Expiry dateAug 27, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61Q19/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are methods and compositions for inducing melanogenesis in a human subject. The method comprises administering to a subject an alpha-MSH analogue, in an effective amount and time to induce melanogenesis by the melanocytes in epidermal tissue of subject without inducing homologous desensitization of the melanocortin-1 receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.